Medication info

Montelukast Chewable Tablets 5 mg (Montelukast Sodium)

Prescription medicationTabletOralExpired
Ingredient · strength
Montelukast Sodium›5.2mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Pink chewable tablets with a convex shape on both sides
Packaging
30 tablets (10 tablets/PTP X 3), 28 tablets (7 tablets/PTP X 4)
Approval status
Expired

MFDS item code 202002837 · Approved 2020.04.22

This product's status changed to Expired on 2025.04.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Prevention and treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis
Who takes it
Adults · Children
Adult dose
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 sheet once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents aged 15 years and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. ○ Directions for taking the dry syrup (applies only to the syrup formulation.) To take, pour 1 sachet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before taking. After opening, suspend in water and take the entire contents immediately (within 15 minutes). Do not leave this medicine suspended in water for an extended period. ○ Directions for taking the granules (applies only to the granule formulation.) The 4 mg granules may be taken orally as is or mixed with a small amount (approximately 5 mL) of soft food, such as infant food, breast milk, or porridge, at or below room temperature. Do not open the package until immediately before taking. After opening, mix with infant food, breast milk, or food and take immediately (within 15 minutes), or take the entire contents as is. Do not leave this medicine mixed with infant food, breast milk, or food for an extended period; discard any remainder. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be consumed immediately after taking it. This medicine may be taken without regard to meals.
Child dose
Children aged 6~14 years: Take 5 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Take 4 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and, when it disintegrates, take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and, when it disintegrates, take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Asthma Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months~under 2 years: Administer 4 mg of this medicine orally once daily in the evening. The efficacy and safety of this medicine for asthma have not been established in infants under 12 months. Allergic rhinitis Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. The efficacy and safety of this medicine for seasonal allergic rhinitis have not been established in infants under 2 years. Infants aged 6 months~under 2 years: Administer 4mg of this medicine orally once daily. The efficacy and safety of this medicine for perennial allergic rhinitis have not been established in infants under 6 months.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and treatment of asthma; relief of symptoms of seasonal and perennial allergic rhinitis

  • Symptoms of asthma and allergic rhinitis
View approved original text

This medication helps prevent the onset of asthma and manage symptoms continuously. It is also used to alleviate symptoms of allergic rhinitis occurring seasonally or throughout the year.

How to take

Adult dose

Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 sheet once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily. Adults and adolescents aged 15 years and older: Place 10 mg of montelukast on the tongue once daily and allow it to dissolve; take without water. ○ Directions for taking the dry syrup (applies only to the syrup formulation.) To take, pour 1 sachet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before taking. After opening, suspend in water and take the entire contents immediately (within 15 minutes). Do not leave this medicine suspended in water for an extended period. ○ Directions for taking the granules (applies only to the granule formulation.) The 4 mg granules may be taken orally as is or mixed with a small amount (approximately 5 mL) of soft food, such as infant food, breast milk, or porridge, at or below room temperature. Do not open the package until immediately before taking. After opening, mix with infant food, breast milk, or food and take immediately (within 15 minutes), or take the entire contents as is. Do not leave this medicine mixed with infant food, breast milk, or food for an extended period; discard any remainder. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be consumed immediately after taking it. This medicine may be taken without regard to meals.

Child dose

Children aged 6~14 years: Take 5 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Take 4 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and, when it disintegrates, take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and, when it disintegrates, take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Asthma Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Infants aged 12 months~under 2 years: Administer 4 mg of this medicine orally once daily in the evening. The efficacy and safety of this medicine for asthma have not been established in infants under 12 months. Allergic rhinitis Children aged 2~5 years: Administer 4 mg of montelukast orally once daily. The efficacy and safety of this medicine for seasonal allergic rhinitis have not been established in infants under 2 years. Infants aged 6 months~under 2 years: Administer 4mg of this medicine orally once daily. The efficacy and safety of this medicine for perennial allergic rhinitis have not been established in infants under 6 months.

Precautions

This medication should not be taken by individuals allergic to this medication or any of its components. Additionally, this medication contains lactose, so those with genetic conditions that prevent lactose digestion should also avoid it. This medication is for patients with asthma or allergic rhinitis and can be used by a wide range of age groups. However, various side effects such as fatigue, headache, abdominal pain, cough, rash, etc., may occur during treatment, so if abnormal symptoms arise, it is essential to consult a doctor. Since this medication is not intended for the treatment of acute attacks of asthma that worsen suddenly, other emergency treatments should be prepared when acute symptoms occur. When used with inhaled corticosteroids, the dosage should be gradually adjusted according to the doctor's instructions, and it should not be suddenly switched to other steroids. During treatment, symptoms from the nervous system may occur, such as anxiety, depression, hallucinations, or suicidal thoughts, so if such changes appear, the patient should inform their doctor immediately. Patients allergic to aspirin or non-steroidal anti-inflammatory drugs should not take those medications concurrently with this drug. During pregnancy or breastfeeding, the safety of this medication has not been fully established, so it should only be taken under a doctor's judgment when necessary. When administering to children, the appropriate dosage and method of use for their age must be followed, and its safety and effectiveness have not been established for infants under 6 months of age. This medication is sensitive to light, so do not open the package until just before taking it, and take it immediately after preparation. It should be stored in a safe place out of the reach of children, and it is recommended not to transfer it to other containers. In the case of overdose, there is no specific antidote, so it is necessary to remove the drug from the gastrointestinal tract and receive symptomatic treatment.

Side effects

  • Weakness
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • indigestion
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
Show 89 more
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otitis
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • ear pain
  • enteritis
  • eczema
  • hives
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory tract infection
  • wheezing
  • otitis media
  • tonsillitis
  • drowsiness
  • aggressive behavior
  • restlessness
  • anxiety
  • depression
  • disorientation
  • attentional disorders
  • sleep disorders
  • hallucinations
  • insomnia
  • memory disorders
  • psychomotor agitation
  • somnambulism
  • suicidal ideation
  • behavioral disorders
  • tics
  • perceptual disturbances
  • decreased perception
  • seizure attacks
  • palpitations
  • epistaxis
  • pulmonary eosinophilia
  • vomiting
  • increased frequency of bleeding
  • thrombocytopenia
  • hypersensitivity reactions
  • anaphylaxis
  • hepatic eosinophilic infiltration
  • pancreatitis
  • cholestatic hepatitis
  • hepatocellular liver damage
  • mixed liver damage
  • angioedema
  • bruising
  • erythema multiforme
  • nodular erythema
  • itching
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • enuresis
  • edema
  • systemic eosinophilia
  • vasculitis-related rash
  • worsening respiratory symptoms
  • cardiac complications
  • neuropathy
  • abdominal pain
  • drowsiness
  • thirst
  • headache
  • vomiting
  • psychomotor agitation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to moisture and light, so it should be stored at room temperature between 1 and 30 degrees Celsius. It is also important to store it in a tightly closed container to prevent air from entering.

Appearance and packaging

Appearance

Pink chewable tablets with a convex shape on both sides

Package unit

30 tablets (10 tablets/PTP X 3), 28 tablets (7 tablets/PTP X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.